Efficacy and Tolerability of 5-Year Adjuvant Imatinib...

  • Main
  • 2018 / 11
  • Efficacy and Tolerability of 5-Year Adjuvant Imatinib...
JAMA Oncology 2018 / 11

Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor

Raut, Chandrajit P., Espat, N. Joseph, Maki, Robert G., Araujo, Dejka M., Trent, Jonathan, Williams, Toni Faith, Purkayastha, D. Das, DeMatteo, Ronald P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
JAMA Oncology
DOI:
10.1001/jamaoncol.2018.4060
Date:
November, 2018
File:
PDF, 367 KB
english, 2018
Conversion to is in progress
Conversion to is failed